Summary of Product Characteristics
last updated on the eMC:
02/02/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 02/02/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 10-Jan-2011 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change of Marketing Authorisation Holder from Cambridge Laboratories to Alliance Pharmaceuticals Ltd
|
|
Updated on 30/09/2003 and displayed until 02/02/2011
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
-
Change to section 5.2 - Pharmacokinetic Properties
|
|
Updated on 26/11/2001 and displayed until 30/09/2003
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 06/07/2001 and displayed until 26/11/2001
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|
Updated on 06/09/1999 and displayed until 06/07/2001
|
Reasons for adding or updating:
|
|
|
|
